FDA Inspection 1097872 — Coastal Bend Blood Center

Coastal Bend Blood Center — FEI 1671283

The FDA completed an inspection of Coastal Bend Blood Center on June 13, 2019 in Corpus Christi, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 13, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Corpus Christi, TX (United States)